Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
20,131.00
19,682.00
20,127.00
19,109.00
17,502.00
17,659.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
20,131.00
19,682.00
20,127.00
19,109.00
17,502.00
17,659.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
6.00
7.00
8.00
9.00
2.00
2.00
General and Administration Expenses
4,615.00
4,550.00
4,477.00
4,069.00
3,903.00
3,896.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
18,792.00
18,519.00
18,488.00
17,013.00
15,790.00
16,161.00
Operating Profit (PBDIT) excl Other Income
1,339.00
1,162.00
1,639.00
2,096.00
1,712.00
1,497.00
Other Income
9.00
-19.00
84.00
71.00
47.00
15.00
Operating Profit (PBDIT)
1,273.00
1,050.00
1,617.00
2,155.00
1,460.00
1,206.00
Interest
6.00
7.00
8.00
9.00
2.00
2.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
558.00
535.00
519.00
547.00
271.00
244.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
699.00
597.00
959.00
1,502.00
1,175.00
845.00
Provision for Tax
241.00
234.00
319.00
455.00
382.00
317.00
Profit After Tax
464.00
380.00
568.00
1,042.00
793.00
528.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
148.35
114.16
170.55
306.19
231.87
154.31
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 2.28% vs -2.21% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 15.16% vs -29.05% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -10.78% vs -8.28% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 22.10% vs -33.14% in Mar 2024
Compare Profit and Loss Results of Sapporo Clinical Laboratory, Inc.
Figures in Million
consolidated - Profit And Loss Results
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
20,131.00
48,393.00
-28,262.00
-58.40%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
20,131.00
48,393.00
-28,262.00
-58.40%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
6.00
63.00
-57.00
-90.48%
General and Administration Expenses
4,615.00
3,623.00
992.00
27.38%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
18,792.00
46,411.00
-27,619.00
-59.51%
Operating Profit (PBDIT) excl Other Income
1,339.00
1,982.00
-643.00
-32.44%
Other Income
9.00
380.00
-371.00
-97.63%
Operating Profit (PBDIT)
1,273.00
2,836.00
-1,563.00
-55.11%
Interest
6.00
63.00
-57.00
-90.48%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
558.00
763.00
-205.00
-26.87%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
699.00
1,901.00
-1,202.00
-63.23%
Provision for Tax
241.00
754.00
-513.00
-68.04%
Profit After Tax
464.00
1,133.00
-669.00
-59.05%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
148.3473
301.3515
-153.00
-50.77%
Profit And Loss - Net Sales
Net Sales 20,131.37 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 2.28% vs -2.21% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,339.13 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 15.16% vs -29.05% in Mar 2024
Profit And Loss - Interest
Interest 6.68 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -10.78% vs -8.28% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 464.18 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 22.10% vs -33.14% in Mar 2024






